Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 10347
Gene Symbol: ABCA7
ABCA7 		0.100 Biomarker disease HPO
Entrez Id: 65057
Gene Symbol: ACD
ACD 		0.100 Biomarker disease HPO
Entrez Id: 50
Gene Symbol: ACO2
ACO2 		0.100 Biomarker disease HPO
Entrez Id: 84059
Gene Symbol: ADGRV1
ADGRV1 		0.100 Biomarker disease HPO
Entrez Id: 213
Gene Symbol: ALB
ALB 		0.010 Biomarker disease BEFREE Increased cerebrospinal fluid albumin and immunoglobulin A fractions forecast cortical atrophy and longitudinal functional deterioration in relapsing-remitting multiple sclerosis. 29226779 2019
Entrez Id: 5832
Gene Symbol: ALDH18A1
ALDH18A1 		0.100 Biomarker disease HPO
Entrez Id: 501
Gene Symbol: ALDH7A1
ALDH7A1 		0.100 Biomarker disease HPO
Entrez Id: 79868
Gene Symbol: ALG13
ALG13 		0.100 CausalMutation disease CLINVAR
Entrez Id: 57679
Gene Symbol: ALS2
ALS2 		0.100 Biomarker disease HPO
Entrez Id: 271
Gene Symbol: AMPD2
AMPD2 		0.100 Biomarker disease HPO
Entrez Id: 8905
Gene Symbol: AP1S2
AP1S2 		0.100 Biomarker disease HPO
Entrez Id: 10717
Gene Symbol: AP4B1
AP4B1 		0.100 Biomarker disease HPO
Entrez Id: 23431
Gene Symbol: AP4E1
AP4E1 		0.100 Biomarker disease HPO
Entrez Id: 9179
Gene Symbol: AP4M1
AP4M1 		0.100 Biomarker disease HPO
Entrez Id: 11154
Gene Symbol: AP4S1
AP4S1 		0.100 Biomarker disease HPO
Entrez Id: 348
Gene Symbol: APOE
APOE 		0.100 Biomarker disease BEFREE These findings indicate that, in the age range of this cohort, ApoE-4 effects on cortical atrophy and cognitive performances of healthy elderly are limited to epsilon(4) homozygous subjects. 15670698 2005
Entrez Id: 348
Gene Symbol: APOE
APOE 		0.100 GeneticVariation disease BEFREE In conclusion, in our sample CI was associated with higher subcortical damage and cortical atrophy but not with APOE-epsilon4 genotype. 19965518 2009
Entrez Id: 348
Gene Symbol: APOE
APOE 		0.100 Biomarker disease BEFREE Higher CAIDE Dementia Risk Score (version without APOE) was significantly associated with higher total tau, more severe MTA, WMC, and global cortical atrophy-frontal subscale. 27143429 2016
Entrez Id: 348
Gene Symbol: APOE
APOE 		0.100 GeneticVariation disease BEFREE The Apolipoprotein E genotype in patients affected by syndromes with focal cortical atrophy. 11311499 2001
Entrez Id: 348
Gene Symbol: APOE
APOE 		0.100 Biomarker disease BEFREE The model shows that, for instance, APOE carriers have a significantly higher pace of cortical atrophy but not earlier atrophy onset. 29780348 2018
Entrez Id: 348
Gene Symbol: APOE
APOE 		0.100 GeneticVariation disease BEFREE Our aim was to define the relationship between APOE epsilon4 allele load and regionally-specific brain cortical atrophy in Alzheimer's Disease (AD). 19013250 2009
Entrez Id: 348
Gene Symbol: APOE
APOE 		0.100 Biomarker disease BEFREE Here we aimed to identify APOE-related patterns of cortical atrophy in AD using an advanced computational anatomy technique. 19349226 2009
Entrez Id: 348
Gene Symbol: APOE
APOE 		0.100 GeneticVariation disease BEFREE Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease. 29278888 2018
Entrez Id: 348
Gene Symbol: APOE
APOE 		0.100 Biomarker disease BEFREE Compared to HC, APOE ε 4 carriers presented cortical atrophy in right cingulate gyrus (R_CG) (GMV: APOE carriers: 8475.23 ± 1940.73 mm3, HC: 9727.34 ± 1311.57 mm3, t = 2.314, p = 0.026, corrected) and left insular (GMT: APOE ε 4 carriers: 3.83 ± 0.37 mm, HC: 4.05 ± 0.25 mm, t = 2.197, p = 0.033, corrected). 27097839 2016
Entrez Id: 348
Gene Symbol: APOE
APOE 		0.100 Biomarker disease BEFREE We identified the prevalence of APOE-ε4 and evaluated its association with cortical atrophy. 30511009 2018